biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Post by roadking08on Sep 24, 2019 6:30pm

155 Views

Post# 30160936

Whole Lotta Love

If you liked and were all in with last years July’s financing at .55 (yes, the one were JD called out Tailwinds has not going to happen, to low) and you really liked this May’s financing at .28, well your really going to really love this weeks at .22
If your only a spectator or a flipper, the trend is your friend, if your a bag holder you must be a lover

Bullboard Posts

Rick Rule’s election insights: Gold, USD, and Canadian gas